Wnt3 and Wnt3a Antibody [J20B9]

N.º de catálogo F2603

Imprimir

Descripción biológica

Especificidad Wnt3 and Wnt3a Antibody [J20B9] detecta niveles endógenos de la proteína total Wnt3 y Wnt3a.
Antecedentes Wnt3 y Wnt3a son glicoproteínas secretadas ricas en cisteína, estrechamente relacionadas, de la familia Wnt que actúan como potentes ligandos para la vía canónica Wnt/beta-catenin, controlando la formación de patrones embrionarios, el mantenimiento de células madre y la homeostasis tisular. Cada proteína tiene ~350–400 aminoácidos y adopta la arquitectura característica de Wnt de “pulgar-índice” con dominios N-terminal y C-terminal estabilizados por múltiples enlaces disulfuro y modificados por N-glicosilación y una crucial O-palmitoleoilación en una serina conservada (Ser212 en Wnt3, Ser209 en Wnt3a), que es necesaria para la unión al transportador Wntless para la secreción y para el acoplamiento de alta afinidad de los receptores Frizzled. Wnt3 y Wnt3a se unen a los complejos receptores Frizzled/LRP5-6 en la superficie celular para reclutar y activar Dishevelled, inhibir el complejo de destrucción Axin/APC/CK1/GSK-3β, estabilizar la β-catenina citosólica e impulsar su acumulación nuclear donde se asocia con TCF/LEF para inducir genes diana como cc-MYC, CCND1 (ciclina D1), AXIN2 y HOXB4 que promueven la proliferación, supervivencia y stemness; Wnt3 y Wnt3a son, por lo tanto, esenciales para la formación del eje, el desarrollo de las extremidades y neural, y la regulación de células madre hematopoyéticas, neurales e intestinales, con efectos parcialmente superpuestos pero específicos del contexto (p. ej., Wnt3a manteniendo la proliferación de precursores neurales, Wnt3 inclinando más fuertemente hacia la neurogénesis en algunos dominios de la médula espinal). Las mutaciones con pérdida de función en WNT3 causan tetraamelia autosómica recesiva con malformaciones graves de las extremidades y craneofaciales, mientras que la sobreexpresión aberrante de la señalización β-catenina impulsada por Wnt3/Wnt3a contribuye a la oncogénesis en cánceres colorrectales, de mama, pulmón y otros al impulsar la entrada incontrolada en el ciclo celular, la EMT y la resistencia a la apoptosis, y la señalización Wnt3a desregulada también se ha implicado en trastornos esqueléticos y neurodegenerativos.

Información de uso

Aplicación WB Dilución
WB
1:10000
Reactividad Human
Fuente Rabbit Monoclonal Antibody MW 39 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/23015196/
  • https://pubmed.ncbi.nlm.nih.gov/34315898/

Datos de aplicación

WB

Validado por Selleck

  • F2603-wb
    Lane 1: CHO, Lane 2: CHO(Human Wnt3a transfected)